Stay updated on Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial
Sign up to get notified when there's something new on the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page.

Latest updates to the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe revision label updated from v3.6.2 to v3.6.3. This indicates a minor deployment update and does not change the study details on the page.SummaryDifference0.0%

- Check19 days agoChange Detected- The page's revision indicator was updated from v3.6.0 to v3.6.2, reflecting a new build. This signals a small site update without altering the study content or primary features.SummaryDifference0.0%

- Check33 days agoChange DetectedThe study page now explicitly states that recruitment has ended ('No longer looking for participants'). It also adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) to guide users in understanding the study record and participation steps.SummaryDifference0.5%

- Check40 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, indicating an internal update to the document version. No visible changes to study details or interface are indicated by this revision.SummaryDifference0.0%

- Check62 days agoChange DetectedFooter revision tag updated from v3.5.3 to v3.5.4, indicating a new build of the page. This change reflects an updated version label without altering the page's substantive content.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page revision marker was updated from v3.5.2 to v3.5.3, indicating a newer site release for ClinicalTrials.gov.SummaryDifference0.0%

Stay in the know with updates to Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page.